<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00437762</url>
  </required_header>
  <id_info>
    <org_study_id>CHUBX 2005/08</org_study_id>
    <nct_id>NCT00437762</nct_id>
  </id_info>
  <brief_title>Effectiveness of Botulinum Toxin Injection in the Tennis Elbow Treatment</brief_title>
  <acronym>TBA</acronym>
  <official_title>Effectiveness of Botulinum Toxin A Injection for the Treatment of Lateral Epicondylitis Unrelieved by Usual Medical Cares : A Double Blind Randomized Controlled Trial Versus Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Bordeaux</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ipsen</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Bordeaux</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Some studies valued the effectiveness of botulinum toxin. Results are contradictory and we
      need more studies. The purpose of the study is to compare the effectiveness of botulinum
      toxin injection with placebo in the treatment of tennis elbow unrelieved by usual medical
      care performed during 6 months. Method : It is a double blind randomized controlled trial.
      Principal criteria of assessment is Pain intensity three months after injection.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Principal Objective : The first aim of the study is to value the effectiveness of
           botulinum toxin injection in the treatment of tennis elbow unrelieved by usual medical
           care performed during 6 months..

        -  Secondary Objective : The second aim of this study is to document the tennis elbow
           history by a one year following after initial injection

        -  Study design : It is a double blind randomized controlled trial. Principal criteria of
           assessment is Pain intensity three months after injection.

        -  Inclusion criteria : tennis elbow during more than 6 months ; signature of consent

        -  Exclusion criteria : Non inclusion criteria : less than 18 years old ; osteoarthritis
           elbow, referred cervical pain, fibromyalgia, pregnancy, myasthenia, polymyositis, SLA,
           anticoagulant treatment, aminosides ; diabetes, alcoholism

        -  Study plan: randomized parallel groups

        -  Number of subjects : 60
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2007</start_date>
  <completion_date type="Actual">June 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Principal criteria of assessment is pain intensity three months after injection.</measure>
    <time_frame>at 3 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain intensity</measure>
    <time_frame>to day 30, 90,180, 365</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of painful days</measure>
    <time_frame>to day 30, 90,180, 365</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of associated treatments.</measure>
    <time_frame>to day 30, 90,180, 365</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Free pain grip strength</measure>
    <time_frame>to day 30, 90,180, 365</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of recidivism after initial relief</measure>
    <time_frame>to day 30, 90,180, 365</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">61</enrollment>
  <condition>Tennis Elbow</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Botulinum Toxin A Injection</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Botulinum Toxin A Injection</intervention_name>
    <description>Botulinum Toxin A Injection</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo injection</intervention_name>
    <description>Placebo Injection</description>
    <arm_group_label>2</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Tennis elbow during more than 6 months

          -  Signature of consent

        Exclusion Criteria:

          -  Less than 18 years old

          -  Osteoarthritis elbow

          -  Referred cervical pain

          -  Fibromyalgia

          -  Pregnancy

          -  Myasthenia

          -  Polymyositis

          -  SLA

          -  Anticoagulant treatment

          -  Aminosides

          -  Diabetes

          -  Alcoholism

          -  Previous botulinum toxin A injections
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mathieu DE SEZE, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Bordeaux</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Unité de médecine orthopédique- Hôpital Pellegrin RDC aile 2.</name>
      <address>
        <city>Bordeaux cedex</city>
        <zip>330076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2007</study_first_submitted>
  <study_first_submitted_qc>February 20, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 21, 2007</study_first_posted>
  <last_update_submitted>February 27, 2013</last_update_submitted>
  <last_update_submitted_qc>February 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lateral epicondylitis, tennis elbow, treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tennis Elbow</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Botulinum Toxins</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

